Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC

Clinical trial NCT06971211 · RECRUITING

Trial details

NCT number: NCT06971211
Sponsor: Jianbin Bi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2024-11-27
Primary completion: 2027-10-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.